Orthopaedic Implants Market - Global Forecast To 2029
商品番号 : SMB-70016
| 出版社 | MarketsandMarkets |
| 出版年月 | 2024年12月 |
| ページ数 | 260 |
| 図表数 | 224 |
| 価格タイプ | シングルユーザライセンス |
| 価格 | USD 4,950 |
| 種別 | 英文調査報告書 |
Report Overview
The global orthopedic implants market is expected to reach 26.47 billion by 2029 from USD 20.94 billion in 2024, at a CAGR of 4.8% from 2024 to 2029. Increased access to various type of orthopedic implants and technological advancements such as use of 3D printing with the manufacturing process has increased demand for the orthopedic implants. Further, increased incidence of accidents and sport injuries that may result in fractures and damage to the joints has enhanced the demand for the orthopedic implants.
世界の整形外科インプラント市場は、2024年の209億4,000万米ドルから2029年までに264億7,000万米ドルに達し、2024年から2029年まで4.8%のCAGRで成長すると予想されています。
“The knee implants segment of type segment held the largest share of the market in 2023”
The orthopedic implants market is segmented based on type into knee implants, hip implants, shoulder implants, elbow implants, foot & ankle implants, wrist implants and other implants. The knee implants accounted for a the highest share in 2023. Increase in technological innovations, rise in number of obesity cases and the favorable reimbursement scenario for knee replacement procedures is anticipated to fuel the growth of the segment. Developments in robotic assisted knee replacement procedures that improves patient outcomes is another factor propelling the segment expansion. For example, compared to traditional surgery, the Mako Total Knee Replacement from Stryker Corporation can result in less discomfort and a shorter recovery period.
“The metals and metal alloys segment of material segment held the largest share of the market in 2023”
The orthopedic implants market can be segmented based on material into metals and metal alloys, ceramics, polymers and hybrid implants. Growing number for joint replacement surgeries such as reverse shoulder arthroplasty and unique properties such as longevity and resistance to corrosion drive the segment growth. Metal alloys are less expensive and more readily available than other materials. This makes them an appropriate choice for patients and other healthcare professionals especially in areas of price-sensitive markets, and is expected to fuel the segment growth.
“The ambulatory and trauma care centers segment for the end user segment is projected to register a significant CAGR during the forecast period.”
The orthopedic implants market is segmented by end-users into hospitals & surgical centers and ambulatory & trauma care centers. The ambulatory and trauma care centers is projected to register significant growthduring the forecast period. According to Definitive Healthcare there is 304% increase in knee replacement procedures performed in ambulatory surgery centers during the period of 2018-2022. The cost-effectiveness and accessibility anticipated to propel the segment growth. Furthermore, reduced recovery time using minimally invasive surgical techniques is expected to support the growth of this segment.
“The market in the Asia Pacific region is expected to witness the highest growth during the forecast period.”
The north america region accounted for major share in 2023. Asia pacific region to grow at the highest CAGR in orthopedic implants market. Healthcare infrastructure and service investments, in the emerging economies, are fostering the demand for orthopedic implants. Furthermore, market leaders have increased their efforts to strengthen their presence in the Asia Pacific market to meet the ever-growing requirement for orthopedic surgeries and joint replacements. According to International Osteoporosis Foundation more than 50% of osteoporotic hip fractures are expected to occur by 2050.
A breakdown of the primary participants referred to for this report is provided below:
- By Company Type: Tier 1–30%, Tier 2–42%, and Tier 3– 28%
- By Designation: Director-level–10%, C-level–14%, and Others–76%
- By Region: North America–40%, Europe–30%, Asia Pacific–22%, Latin America–6%, and Middle East & Africa – 2%
The prominent players in the orthopedic implants market are as Stryker Corporation (US), Zimmer Biomet Holdings,Inc. (US), Johnson & Johnson MedTech (US), Smith+Nephew (UK), B. Braun (Germany), Globus Medical, Inc. (US), Arthrex, Inc.(US), Enovis (US), Acumed LLC (US), Orthofix Medical Inc.(US) , MicroPort Scientiifc Corporation (China), CONMED Corporation (US), Medacta International (Switzerland), Paragon 28, Inc. (US) and, Meril Life Sciences Pvt. Ltd. (India)
The study includes as in-depth competitive analysis of these key players in the authentication and brand protection market, with their company profiles recent developments, and key market stratergies
Research Coverage
This report studies the orthopedic implants market based on type, material, end user, and region. It also covers the factors affecting market growth, analyzes the various opportunities and challenges in the market, and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their growth trends and forecasts the revenue of the market segments with respect to five main regions (and the respective countries in these regions).
Reasons to Buy the Report
The report will help market leaders and new entrants with information on the closest approximations of the revenue numbers for the overall orthopedic implants market and the subsegments. It will also help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the market pulse and provides information on key market drivers, restraints, challenges, and opportunities.
This report provides insights on the following pointers:
- Analysis of key drivers (increasing demand for minimally invasive orthopedic surgical procedures and rising number of sports injuries, increasing prevalence of orthopedic diseases and disorders, and increasing research funding and awareness initiatives), restraints (risk and complications associated with orthopedic surgical procedures, high costs of orthopedic surgery), opportunities (growth opportunities in merging markets, advancements in robotic surgery and 3D printing), and challenges (dearth of skilled orthopedic surgeons) influencing the growth of the orthopedic implants market
- Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the orthopedic implants market
- Market Development: Comprehensive information about lucrative markets–the report analyses the orthopedic implants market across varied regions.
- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the orthopedic implants market
- Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players, such as Stryker Corporation (US), Zimmer Biomet Holdings, Inc. (US), Johnson & Johnson MedTech (US), Smith+Nephew (UK), B. Braun (Germany).
Table of Contents
1 INTRODUCTION 22
1.1 STUDY OBJECTIVES 22
1.2 MARKET DEFINITION 22
1.3 STUDY SCOPE 23
1.3.1 MARKETS COVERED AND REGIONS CONSIDERED 23
1.3.2 INCLUSIONS AND EXCLUSIONS 23
1.3.3 YEARS CONSIDERED 24
1.3.4 CURRENCY CONSIDERED 24
1.4 STAKEHOLDERS 24
1.5 IMPACT OF AI/GEN AI 24
2 RESEARCH METHODOLOGY 25
2.1 RESEARCH DATA 25
2.1.1 SECONDARY DATA 26
2.1.1.1 Key sources for secondary research 26
2.1.2 PRIMARY DATA 26
2.1.2.1 Key primary sources 27
2.1.2.2 Key industry insights 28
2.1.2.3 Breakdown of primary interviews 28
2.2 MARKET SIZE ESTIMATION 29
2.2.1 BOTTOM-UP APPROACH 31
2.2.1.1 Company revenue estimation approach 31
2.2.1.2 Customer-based market estimation 32
2.2.1.3 Growth forecast approach 32
2.2.1.4 CAGR projections 33
2.3 DATA TRIANGULATION 33
2.4 MARKET SHARE ANALYSIS 34
2.5 RESEARCH ASSUMPTIONS 35
2.5.1 PARAMETRIC ASSUMPTIONS 35
2.5.2 GROWTH RATE ASSUMPTIONS 35
2.6 RESEARCH LIMITATIONS 35
2.7 RISK ASSESSMENT 36
3 EXECUTIVE SUMMARY 37
4 PREMIUM INSIGHTS 40
4.1 ORTHOPEDIC IMPLANTS MARKET OVERVIEW 40
4.2 NORTH AMERICA: ORTHOPEDIC IMPLANTS MARKET, BY TYPE 41
4.3 EUROPE: ORTHOPEDIC IMPLANTS MARKET, BY MATERIAL 41
4.4 ASIA PACIFIC: ORTHOPEDIC IMPLANTS MARKET, BY END USER (USD MILLION) 42
4.5 GEOGRAPHIC GROWTH OPPORTUNITIES IN ORTHOPEDIC IMPLANTS MARKET 43
5 MARKET OVERVIEW 44
5.1 INTRODUCTION 44
5.2 MARKET DYNAMICS 44
5.2.1 DRIVERS 45
5.2.1.1 Rising prevalence of orthopedic diseases and disorders 45
5.2.1.2 Increasing demand for minimally invasive surgery 45
5.2.1.3 Rising number of sports injuries 46
5.2.1.4 Increasing research funding and awareness initiatives 46
5.2.2 RESTRAINTS 47
5.2.2.1 Risks and complications associated with orthopedic
surgical procedures 47
5.2.2.2 High cost of orthopedic surgery 47
5.2.3 OPPORTUNITIES 47
5.2.3.1 Advancements in robotic surgery and 3D printing 47
5.2.3.2 Growth opportunities in emerging markets 48
5.2.4 CHALLENGES 49
5.2.4.1 Dearth of skilled orthopedic surgeons 49
5.3 VALUE CHAIN ANALYSIS 50
5.3.1 RESEARCH & PRODUCT DEVELOPMENT 50
5.3.2 RAW MATERIAL PROCUREMENT AND MANUFACTURING 51
5.3.3 DISTRIBUTION, MARKETING & SALES, AND POST-SALES SERVICES 51
5.4 SUPPLY CHAIN ANALYSIS 52
5.4.1 MANUFACTURERS 52
5.4.1.1 Prominent companies 52
5.4.1.2 Small and medium-sized enterprises 52
5.4.2 END USERS 53
5.5 ECOSYSTEM ANALYSIS 53
5.6 REGULATORY LANDSCAPE 54
5.6.1 REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 54
5.6.2 REGULATORY ANALYSIS 57
5.6.2.1 North America 57
5.6.2.1.1 US 57
5.6.2.1.2 Canada 59
5.6.2.2 Europe 61
5.6.2.3 Asia Pacific 63
5.6.2.3.1 Japan 63
5.6.2.3.2 China 64
5.6.2.3.3 India 65
5.6.2.4 Latin America 66
5.6.2.4.1 Brazil 66
5.6.3 REGULATORY APPROVALS 66
5.7 REIMBURSEMENT SCENARIO 66
5.8 INVESTMENT AND FUNDING SCENARIO 68
5.9 PRICING ANALYSIS 70
5.9.1 AVERAGE SELLING PRICE, BY REGION 70
5.9.2 AVERAGE SELLING PRICE, BY KEY PLAYER 72
5.10 TRADE ANALYSIS 72
5.10.1 IMPORT DATA FOR HS CODE 9021 72
5.10.2 EXPORT DATA FOR HS CODE 9021 73
5.11 PATENT ANALYSIS 74
5.12 PORTER’S FIVE FORCES ANALYSIS 76
5.12.1 THREAT OF NEW ENTRANTS 77
5.12.2 THREAT OF SUBSTITUTES 77
5.12.3 BARGAINING POWER OF SUPPLIERS 77
5.12.4 BARGAINING POWER OF BUYERS 77
5.12.5 INTENSITY OF COMPETITIVE RIVALRY 77
5.13 KEY STAKEHOLDERS AND BUYING CRITERIA 78
5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS 78
5.13.2 KEY BUYING CRITERIA 79
5.14 KEY CONFERENCES AND EVENTS, 2024–2025 80
5.15 CASE STUDY ANALYSIS 81
5.15.1 DIGITAL PLATFORM DESIGNED TO IMPROVE PATIENT CARE PATHWAYS 81
5.15.2 PARTIAL KNEE ARTHROPLASTY PERFORMED WITH ROSA
PARTIAL KNEE SYSTEM 82
5.15.3 ACCURATE DATA GENERATION WITH SHAPEGRABBER 3D 82
5.16 TECHNOLOGY ANALYSIS 82
5.16.1 KEY TECHNOLOGIES 82
5.16.1.1 3D printing/additive manufacturing 82
5.16.2 COMPLEMENTARY TECHNOLOGIES 83
5.16.2.1 Robotic orthopedic surgery 83
5.16.3 ADJACENT TECHNOLOGIES 83
5.16.3.1 Diagnostic imaging 83
5.17 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS 84
5.18 UNMET NEEDS 84
5.19 IMPACT OF AI/GEN AI ON ORTHOPEDIC IMPLANTS MARKET 85
5.19.1 KEY USE CASES 86
6 ORTHOPEDIC IMPLANTS MARKET, BY TYPE 88
6.1 INTRODUCTION 89
6.2 KNEE IMPLANTS 89
6.2.1 ONGOING INNOVATION IN KNEE IMPLANTS TO SUPPORT GROWTH 89
6.3 HIP IMPLANTS 90
6.3.1 RISING NUMBER OF HIP FRACTURES AND INCREASING SUCCESS RATE OF HIP ARTHROPLASTY TO SUPPORT MARKET GROWTH 90
6.4 SHOULDER IMPLANTS 91
6.4.1 LAUNCH OF NEW SHOULDER REPLACEMENT IMPLANTS AND RISING POPULARITY OF REVERSE SHOULDER ARTHROPLASTY TO
SUPPORT MARKET GROWTH 91
6.5 ELBOW IMPLANTS 92
6.5.1 INCREASING FREQUENCY OF ELBOW JOINT FRACTURES AND GROWTH IN ELDERLY POPULATION TO DRIVE MARKET 92
6.6 FOOT & ANKLE IMPLANTS 93
6.6.1 RISING NUMBER OF ANKLE REPLACEMENT PROCEDURES TO
FUEL MARKET GROWTH 93
6.7 WRIST IMPLANTS 94
6.7.1 GROWING NUMBER OF WRIST REPLACEMENT PROCEDURES
TO DRIVE MARKET 94
6.8 OTHER IMPLANTS 95
7 ORTHOPEDIC IMPLANTS MARKET, BY MATERIAL 96
7.1 INTRODUCTION 97
7.2 HYBRID IMPLANTS 97
7.2.1 IMPROVED BIOCOMPATIBILITY, BETTER MECHANICAL PERFORMANCE,
AND REDUCED RISKS OF REVISION SURGERIES TO DRIVE MARKET 97
7.3 METALS & METAL ALLOYS 98
7.3.1 STAINLESS STEEL 99
7.3.1.1 Growing affordability and availability of stainless steel to
drive market 99
7.3.2 TITANIUM ALLOYS 100
7.3.2.1 Biocompatibility and ability to withstand high stress to
propel adoption 100
7.3.3 OTHER METALS & METAL ALLOYS 100
7.4 POLYMERS 101
7.4.1 DESIGN FLEXIBILITY AND TUNABLE PROPERTIES OF POLYMERS
TO PROPEL GROWTH 101
7.5 CERAMICS 102
7.5.1 LOW FRICTIONAL PROPERTIES AND RESISTANCE AGAINST WEAR
TO FUEL MARKET 102
8 ORTHOPEDIC IMPLANTS MARKET, BY END USER 103
8.1 INTRODUCTION 104
8.2 HOSPITALS & SURGICAL CENTERS 104
8.2.1 RISING NUMBER OF ORTHOPEDIC SURGERIES TO DRIVE MARKET 104
8.3 AMBULATORY & TRAUMA CARE CENTERS 105
8.3.1 COST-EFFECTIVE TREATMENT OFFERED BY AMBULATORY CARE CENTERS TO PROPEL MARKET GROWTH 105
9 ORTHOPEDIC IMPLANTS MARKET, BY REGION 107
9.1 INTRODUCTION 108
9.2 NORTH AMERICA 108
9.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 111
9.2.2 US 112
9.2.2.1 US to dominate North American orthopedic implants market
during forecast period 112
9.2.3 CANADA 113
9.2.3.1 Rising incidence of degenerative bone diseases to
support market growth 113
9.3 EUROPE 114
9.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 114
9.3.2 GERMANY 117
9.3.2.1 Germany to account for largest market share in Europe 117
9.3.3 FRANCE 118
9.3.3.1 Increasing obesity and significant adoption of orthopedic implants to support market growth 118
9.3.4 UK 119
9.3.4.1 Increasing awareness of orthopedic conditions to drive adoption of innovative treatments 119
9.3.5 ITALY 120
9.3.5.1 Increasing awareness of preventive care for musculoskeletal injuries to drive market 120
9.3.6 SPAIN 121
9.3.6.1 Growing preference for minimally invasive surgical procedures to drive market 121
9.3.7 REST OF EUROPE 122
9.4 ASIA PACIFIC 123
9.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 123
9.4.2 JAPAN 128
9.4.2.1 Rapidly growing geriatric population to propel market 128
9.4.3 CHINA 128
9.4.3.1 Expanding target patient population to drive market 128
9.4.4 INDIA 129
9.4.4.1 Increasing number of hospitals adopting robotic-assisted joint replacement surgery to support market growth 129
9.4.5 AUSTRALIA 130
9.4.5.1 Favorable government initiatives to promote market growth 130
9.4.6 SOUTH KOREA 131
9.4.6.1 Rising R&D and funding to drive market 131
9.4.7 REST OF ASIA PACIFIC 132
9.5 LATIN AMERICA 132
9.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 133
9.5.2 BRAZIL 136
9.5.2.1 Strong presence of global players to drive market 136
9.5.3 MEXICO 137
9.5.3.1 Favorable investment scenario for medical device manufacturers to favor market growth 137
9.5.4 REST OF LATIN AMERICA 138
9.6 MIDDLE EAST & AFRICA 139
9.6.1 GROWING AVAILABILITY OF HIGH-QUALITY TREATMENTS TO DRIVE MARKET 139
9.6.2 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 139
10 COMPETITIVE LANDSCAPE 143
10.1 OVERVIEW 143
10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2021-2024 143
10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN
ORTHOPEDIC IMPLANTS MARKET 144
10.3 REVENUE ANALYSIS, 2019−2023 147
10.4 MARKET SHARE ANALYSIS 148
10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023 149
10.5.1 STARS 149
10.5.2 EMERGING LEADERS 149
10.5.3 PERVASIVE PLAYERS 150
10.5.4 PARTICIPANTS 150
10.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023 151
10.5.5.1 Company footprint 151
10.5.5.2 Region footprint 152
10.5.5.3 Type footprint 153
10.5.5.4 Material footprint 154
10.5.5.5 End-user footprint 155
10.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023 155
10.6.1 PROGRESSIVE COMPANIES 155
10.6.2 RESPONSIVE COMPANIES 155
10.6.3 DYNAMIC COMPANIES 156
10.6.4 STARTING BLOCKS 156
10.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023 157
10.7 VALUATION & FINANCIAL METRICS 159
10.7.1 FINANCIAL METRICS 159
10.7.2 COMPANY VALUATION 160
10.8 BRAND/PRODUCT COMPARISON 161
10.9 COMPETITIVE SCENARIO 161
10.9.1 PRODUCT LAUNCHES & APPROVALS 161
10.9.2 DEALS 162
10.9.3 EXPANSIONS 162
11 COMPANY PROFILES 163
11.1 KEY PLAYERS 163
11.1.1 ZIMMER BIOMET HOLDINGS, INC. 163
11.1.1.1 Business overview 163
11.1.1.2 Products offered 164
11.1.1.3 Recent developments 167
11.1.1.3.1 Product approvals 167
11.1.1.3.2 Deals 167
11.1.1.4 MnM view 167
11.1.1.4.1 Key strengths 167
11.1.1.4.2 Strategic choices 168
11.1.1.4.3 Weaknesses and competitive threats 168
11.1.2 STRYKER CORPORATION 169
11.1.2.1 Business overview 169
11.1.2.2 Products offered 170
11.1.2.3 Recent developments 174
11.1.2.3.1 Deals 174
11.1.2.3.2 Expansions 174
11.1.2.4 MnM view 174
11.1.2.4.1 Right to win 174
11.1.2.4.2 Strategic choices 174
11.1.2.4.3 Weaknesses and competitive threats 175
11.1.3 JOHNSON & JOHNSON MEDTECH 176
11.1.3.1 Business overview 176
11.1.3.2 Products offered 177
11.1.3.3 Recent developments 179
11.1.3.3.1 Product launches & approvals 179
11.1.3.3.2 Deals 180
11.1.3.4 MnM view 180
11.1.3.4.1 Right to win 180
11.1.3.4.2 Strategic choices 180
11.1.3.4.3 Weaknesses and competitive threats 180
11.1.4 SMITH+NEPHEW 181
11.1.4.1 Business overview 181
11.1.4.2 Products offered 182
11.1.4.3 Recent developments 184
11.1.4.3.1 Product launches & approvals 184
11.1.4.3.2 Deals 185
11.1.4.3.3 Expansions 185
11.1.5 B. BRAUN 186
11.1.5.1 Business overview 186
11.1.5.2 Products offered 187
11.1.6 GLOBUS MEDICAL, INC. 190
11.1.6.1 Business overview 190
11.1.6.2 Products offered 191
11.1.6.3 Recent developments 192
11.1.6.3.1 Product launches & approvals 192
11.1.6.3.2 Deals 193
11.1.7 ARTHREX, INC. 194
11.1.7.1 Business overview 194
11.1.7.2 Products offered 194
11.1.8 ENOVIS 200
11.1.8.1 Business overview 200
11.1.8.2 Products offered 201
11.1.8.3 Recent developments 203
11.1.8.3.1 Product launches 203
11.1.8.3.2 Deals 203
11.1.8.3.3 Expansions 204
11.1.9 ACUMED LLC 205
11.1.9.1 Business overview 205
11.1.9.2 Products offered 205
11.1.9.3 Recent developments 207
11.1.9.3.1 Product launches 207
11.1.9.3.2 Deals 208
11.1.9.3.3 Expansions 208
11.1.10 ORTHOFIX MEDICAL INC. 209
11.1.10.1 Business overview 209
11.1.10.2 Products offered 210
11.1.10.3 Recent developments 212
11.1.10.3.1 Product launches & approvals 212
11.1.10.3.2 Deals 212
11.1.11 MICROPORT SCIENTIFIC CORPORATION 213
11.1.11.1 Business overview 213
11.1.11.2 Products offered 214
11.1.11.3 Recent developments 215
11.1.11.3.1 Product launches 215
11.1.11.3.2 Deals 216
11.1.12 CONMED CORPORATION 217
11.1.12.1 Business overview 217
11.1.12.2 Products offered 218
11.1.12.3 Recent developments 219
11.1.12.3.1 Deals 219
11.1.13 MEDACTA INTERNATIONAL 220
11.1.13.1 Business overview 220
11.1.13.2 Products offered 221
11.1.13.3 Recent developments 222
11.1.13.3.1 Product approvals 222
11.1.13.3.2 Deals 222
11.1.13.3.3 Expansions 223
11.1.14 PARAGON 28, INC. 224
11.1.14.1 Business overview 224
11.1.14.2 Products offered 225
11.1.14.3 Recent developments 227
11.1.14.3.1 Product launches & approvals 227
11.1.14.3.2 Deals 228
11.1.15 MERIL LIFE SCIENCES PVT. LTD. 229
11.1.15.1 Business overview 229
11.1.15.2 Products offered 229
11.1.15.3 Recent developments 231
11.1.15.3.1 Expansions 231
11.2 OTHER PLAYERS 232
11.2.1 FH ORTHO SAS 232
11.2.2 SYMBIOS ORTHOPÉDIE S.A. 233
11.2.3 MADISON ORTHO 234
11.2.4 GREEN SURGICALS PVT. LTD. 236
11.2.5 SIORA SURGICALS PRIVATE LIMITED 241
11.2.6 ORTHOPEDIATRICS CORP. 244
11.2.7 RESTOR3D 245
11.2.8 DOUBLE MEDICAL TECHNOLOGY INC. 246
11.2.9 TREACE MEDICAL CONCEPTS, INC. 249
11.2.10 AK MEDICAL HOLDINGS LIMITED 250
12 APPENDIX 252
12.1 DISCUSSION GUIDE 252
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 256
12.3 CUSTOMIZATION OPTIONS 258
12.4 RELATED REPORTS 258
12.5 AUTHOR DETAILS 259
LIST OF TABLES
TABLE 1 ORTHOPEDIC IMPLANTS MARKET: INCLUSIONS AND EXCLUSIONS 23
TABLE 2 GRANTS AND FUNDING OPPORTUNITIES IN ORTHOPEDIC IMPLANTS MARKET 46
TABLE 3 ORTHOPEDIC IMPLANTS MARKET: ROLE OF COMPANIES IN ECOSYSTEM 53
TABLE 4 NORTH AMERICA: KEY REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 54
TABLE 5 EUROPE: KEY REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 55
TABLE 6 ASIA PACIFIC: KEY REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 55
TABLE 7 LATIN AMERICA: KEY REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 56
TABLE 8 MIDDLE EAST & AFRICA: KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 57
TABLE 9 US FDA: MEDICAL DEVICE CLASSIFICATION 57
TABLE 10 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 58
TABLE 11 US: CLASSIFICATION OF ORTHOPEDIC IMPLANTS 58
TABLE 12 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 59
TABLE 13 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PHARMACEUTICAL AND MEDICAL DEVICE AGENCY (PMDA) 63
TABLE 14 CHINA: CLASSIFICATION OF MEDICAL DEVICES 64
TABLE 15 REGULATORY APPROVALS FOR ORTHOPEDIC IMPLANTS, BY COUNTRY 66
TABLE 16 MEDICAL REIMBURSEMENT CODES FOR ORTHOPEDIC
IMPLANTATION SERVICES, 2023 67
TABLE 17 AVERAGE SELLING PRICE TREND OF ORTHOPEDIC IMPLANTS,
BY REGION, 2021–2023 (USD) 71
TABLE 18 AVERAGE SELLING PRICE OF ORTHOPEDIC IMPLANTS,
BY KEY PLAYER, 2023 (USD) 72
TABLE 19 IMPORT DATA FOR ORTHOPEDIC IMPLANTS (HS CODE 9021),
BY COUNTRY, 2019–2023 (USD THOUSAND) 73
TABLE 20 EXPORT DATA FOR ORTHOPEDIC IMPLANTS (HS CODE 9021),
BY COUNTRY, 2019–2023 (USD THOUSAND) 73
TABLE 21 INNOVATIONS AND PATENT REGISTRATIONS, JANUARY 2021–SEPTEMBER 2024 75
TABLE 22 ORTHOPEDIC IMPLANTS MARKET: PORTER’S FIVE FORCES 76
TABLE 23 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS
OF ORTHOPEDIC IMPLANTS 78
TABLE 24 INFLUENCE OF END USERS ON PURCHASE OF ORTHOPEDIC IMPLANTS,
BY END USER 79
TABLE 25 ORTHOPEDIC IMPLANTS MARKET: LIST OF CONFERENCES AND EVENTS 80
TABLE 26 ORTHOPEDIC IMPLANTS MARKET: CURRENT UNMET NEEDS 84
TABLE 27 ORTHOPEDIC IMPLANTS MARKET: INTENSITY OF CURRENT UNMET NEEDS 85
TABLE 28 ORTHOPEDIC IMPLANTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 89
TABLE 29 KNEE IMPLANTS MARKET, BY REGION, 2022–2029 (USD MILLION) 90
TABLE 30 HIP IMPLANTS MARKET, BY REGION, 2022–2029 (USD MILLION) 91
TABLE 31 SHOULDER IMPLANTS MARKET, BY REGION, 2022–2029 (USD MILLION) 92
TABLE 32 ELBOW IMPLANTS MARKET, BY REGION, 2022–2029 (USD MILLION) 92
TABLE 33 FOOT & ANKLE IMPLANTS MARKET, BY REGION, 2022–2029 (USD MILLION) 93
TABLE 34 WRIST IMPLANTS MARKET, BY REGION, 2022–2029 (USD MILLION) 94
TABLE 35 OTHER ORTHOPEDIC IMPLANTS MARKET, BY REGION, 2022–2029 (USD MILLION) 95
TABLE 36 ORTHOPEDIC IMPLANTS MARKET, BY MATERIAL, 2022–2029 (USD MILLION) 97
TABLE 37 HYBRID IMPLANTS MARKET, BY REGION, 2022–2029 (USD MILLION) 98
TABLE 38 METAL & METAL ALLOY IMPLANTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 98
TABLE 39 METAL & METAL ALLOY IMPLANTS MARKET, BY REGION,
2022–2029 (USD MILLION) 99
TABLE 40 STAINLESS STEEL IMPLANTS MARKET, BY REGION, 2022–2029 (USD MILLION) 99
TABLE 41 TITANIUM ALLOY IMPLANTS MARKET, BY REGION, 2022–2029 (USD MILLION) 100
TABLE 42 OTHER METAL & METAL ALLOY IMPLANTS MARKET, BY REGION,
2022–2029 (USD MILLION) 101
TABLE 43 POLYMER IMPLANTS MARKET, BY REGION, 2022–2029 (USD MILLION) 102
TABLE 44 CERAMIC IMPLANTS MARKET, BY REGION, 2022–2029 (USD MILLION) 102
TABLE 45 ORTHOPEDIC IMPLANTS MARKET, BY END USER, 2022–2029 (USD MILLION) 104
TABLE 46 ORTHOPEDIC IMPLANTS MARKET FOR HOSPITALS & SURGICAL CENTERS
BY REGION, 2022–2029 (USD MILLION) 105
TABLE 47 ORTHOPEDIC IMPLANTS MARKET FOR AMBULATORY & TRAUMA CARE CENTERS, BY REGION, 2022–2029 (USD MILLION) 106
TABLE 48 ORTHOPEDIC IMPLANTS MARKET, BY REGION, 2022–2029 (USD MILLION) 108
TABLE 49 NORTH AMERICA: ORTHOPEDIC IMPLANTS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 109
TABLE 50 NORTH AMERICA: ORTHOPEDIC IMPLANTS MARKET, BY TYPE,
2022–2029 (USD MILLION) 110
TABLE 51 NORTH AMERICA: ORTHOPEDIC IMPLANTS MARKET, BY MATERIAL,
2022–2029 (USD MILLION) 110
TABLE 52 NORTH AMERICA: METAL & METAL ALLOY IMPLANTS MARKET, BY TYPE,
2022–2029 (USD MILLION) 111
TABLE 53 NORTH AMERICA: ORTHOPEDIC IMPLANTS MARKET, BY END USER,
2022–2029 (USD MILLION) 111
TABLE 54 NORTH AMERICA: KEY MACROINDICATORS 112
TABLE 55 US: ORTHOPEDIC IMPLANTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 113
TABLE 56 CANADA: ORTHOPEDIC IMPLANTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 114
TABLE 57 EUROPE: KEY MACROINDICATORS 115
TABLE 58 EUROPE: ORTHOPEDIC IMPLANTS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 115
TABLE 59 EUROPE: ORTHOPEDIC IMPLANTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 116
TABLE 60 EUROPE: ORTHOPEDIC IMPLANTS MARKET, BY MATERIAL,
2022–2029 (USD MILLION) 116
TABLE 61 EUROPE: METAL & METAL ALLOY IMPLANTS MARKET, BY TYPE,
2022–2029 (USD MILLION) 117
TABLE 62 EUROPE: ORTHOPEDIC IMPLANTS MARKET, BY END USER,
2022–2029 (USD MILLION) 117
TABLE 63 GERMANY: ORTHOPEDIC IMPLANTS MARKET, BY TYPE,
2022–2029 (USD MILLION) 118
TABLE 64 FRANCE: ORTHOPEDIC IMPLANTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 119
TABLE 65 UK: ORTHOPEDIC IMPLANTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 120
TABLE 66 ITALY: ORTHOPEDIC IMPLANTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 121
TABLE 67 SPAIN: ORTHOPEDIC IMPLANTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 122
TABLE 68 REST OF EUROPE: ORTHOPEDIC IMPLANTS MARKET, BY TYPE,
2022–2029 (USD MILLION) 123
TABLE 69 ASIA PACIFIC: KEY MACROINDICATORS 124
TABLE 70 ASIA PACIFIC: ORTHOPEDIC IMPLANTS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 126
TABLE 71 ASIA PACIFIC: ORTHOPEDIC IMPLANTS MARKET, BY TYPE,
2022–2029 (USD MILLION) 126
TABLE 72 ASIA PACIFIC: ORTHOPEDIC IMPLANTS MARKET, BY MATERIAL,
2022–2029 (USD MILLION) 127
TABLE 73 ASIA PACIFIC: METAL & METAL ALLOY IMPLANTS MARKET, BY TYPE,
2022–2029 (USD MILLION) 127
TABLE 74 ASIA PACIFIC: ORTHOPEDIC IMPLANTS MARKET, BY END USER,
2022–2029 (USD MILLION) 127
TABLE 75 JAPAN: ORTHOPEDIC IMPLANTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 128
TABLE 76 CHINA: ORTHOPEDIC IMPLANTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 129
TABLE 77 INDIA: ORTHOPEDIC IMPLANTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 130
TABLE 78 AUSTRALIA: ORTHOPEDIC IMPLANTS MARKET, BY TYPE,
2022–2029 (USD MILLION) 131
TABLE 79 SOUTH KOREA: ORTHOPEDIC IMPLANTS MARKET, BY TYPE,
2022–2029 (USD MILLION) 131
TABLE 80 REST OF ASIA PACIFIC: ORTHOPEDIC IMPLANTS MARKET, BY TYPE,
2022–2029 (USD MILLION) 132
TABLE 81 LATIN AMERICA: KEY MACROINDICATORS 134
TABLE 82 LATIN AMERICA: ORTHOPEDIC IMPLANTS MARKET, BY COUNTRY,
2022–2029 (USD MILLION) 134
TABLE 83 LATIN AMERICA: ORTHOPEDIC IMPLANTS MARKET, BY TYPE,
2022–2029 (USD MILLION) 135
TABLE 84 LATIN AMERICA: ORTHOPEDIC IMPLANTS MARKET, BY MATERIAL,
2022–2029 (USD MILLION) 135
TABLE 85 LATIN AMERICA: METAL & METAL ALLOY IMPLANTS MARKET, BY TYPE,
2022–2029 (USD MILLION) 136
TABLE 86 LATIN AMERICA: ORTHOPEDIC IMPLANTS MARKET, BY END USER,
2022–2029 (USD MILLION) 136
TABLE 87 BRAZIL: ORTHOPEDIC IMPLANTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 137
TABLE 88 MEXICO: ORTHOPEDIC IMPLANTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 138
TABLE 89 REST OF LATIN AMERICA: ORTHOPEDIC IMPLANTS MARKET, BY TYPE,
2022–2029 (USD MILLION) 139
TABLE 90 MIDDLE EAST & AFRICA: KEY MACROINDICATORS 140
TABLE 91 MIDDLE EAST & AFRICA: ORTHOPEDIC IMPLANTS MARKET, BY REGION,
2022–2029 (USD MILLION) 140
TABLE 92 MIDDLE EAST & AFRICA: ORTHOPEDIC IMPLANTS MARKET, BY TYPE,
2022–2029 (USD MILLION) 141
TABLE 93 MIDDLE EAST & AFRICA: ORTHOPEDIC IMPLANTS MARKET, BY MATERIAL,
2022–2029 (USD MILLION) 141
TABLE 94 MIDDLE EAST & AFRICA: METAL & METAL ALLOY IMPLANTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 142
TABLE 95 MIDDLE EAST & AFRICA: ORTHOPEDIC IMPLANTS MARKET, BY END USER,
2022–2029 (USD MILLION) 142
TABLE 96 ORTHOPEDIC IMPLANTS MARKET: OVERVIEW OF STRATEGIES DEPLOYED
BY KEY MANUFACTURING COMPANIES, 2021−2024 144
TABLE 97 ORTHOPEDIC IMPLANTS MARKET: DEGREE OF COMPETITION 148
TABLE 98 ORTHOPEDIC IMPLANTS MARKET: REGION FOOTPRINT 152
TABLE 99 ORTHOPEDIC IMPLANTS MARKET: TYPE FOOTPRINT 153
TABLE 100 ORTHOPEDIC IMPLANTS MARKET: MATERIAL FOOTPRINT 154
TABLE 101 ORTHOPEDIC IMPLANTS MARKET: END-USER FOOTPRINT 155
TABLE 102 ORTHOPEDIC IMPLANTS MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS 157
TABLE 103 ORTHOPEDIC IMPLANTS MARKET: COMPETITIVE BENCHMARKING OF
KEY EMERGING PLAYERS/STARTUPS 158
TABLE 104 ORTHOPEDIC IMPLANTS MARKET: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2021– OCTOBER 2024 161
TABLE 105 ORTHOPEDIC IMPLANTS MARKET: DEALS, JANUARY 2021– OCTOBER 2024 162
TABLE 106 ORTHOPEDIC IMPLANTS MARKET: EXPANSIONS, JANUARY 2021–OCTOBER 2024 162
TABLE 107 ZIMMER BIOMET HOLDINGS: COMPANY OVERVIEW 163
TABLE 108 ZIMMER BIOMET HOLDINGS: PRODUCTS OFFERED 164
TABLE 109 ZIMMER BIOMET HOLDINGS: PRODUCT APPROVALS,
JANUARY 2021−SEPTEMBER 2024 167
TABLE 110 ZIMMER BIOMET HOLDINGS: DEALS, JANUARY 2021−SEPTEMBER 2024 167
TABLE 111 STRYKER CORPORATION: COMPANY OVERVIEW 169
TABLE 112 STRYKER CORPORATION: PRODUCTS OFFERED 170
TABLE 113 STRYKER CORPORATION: DEALS, JANUARY 2021−SEPTEMBER 2024 174
TABLE 114 STRYKER CORPORATION: EXPANSIONS, JANUARY 2021−SEPTEMBER 2024 174
TABLE 115 JOHNSON & JOHNSON MEDTECH: COMPANY OVERVIEW 176
TABLE 116 JOHNSON & JOHNSON MEDTECH: PRODUCTS OFFERED 177
TABLE 117 JOHNSON & JOHNSON MEDTECH: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2021−SEPTEMBER 2024 179
TABLE 118 JOHNSON & JOHNSON MEDTECH: DEALS, JANUARY 2021−SEPTEMBER 2024 180
TABLE 119 SMITH+NEPHEW: COMPANY OVERVIEW 181
TABLE 120 SMITH+NEPHEW: PRODUCTS OFFERED 182
TABLE 121 SMITH+NEPHEW: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021−SEPTEMBER 2024 184
TABLE 122 SMITH+NEPHEW: DEALS, JANUARY 2021−SEPTEMBER 2024 185
TABLE 123 SMITH+NEPHEW: EXPANSIONS, JANUARY 2021− AUGUST 2024 185
TABLE 124 B. BRAUN: COMPANY OVERVIEW 186
TABLE 125 B. BRAUN: PRODUCTS OFFERED 187
TABLE 126 GLOBUS MEDICAL: COMPANY OVERVIEW 190
TABLE 127 GLOBUS MEDICAL: PRODUCTS OFFERED 191
TABLE 128 GLOBUS MEDICAL: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2021−SEPTEMBER 2024 192
TABLE 129 GLOBUS MEDICAL: DEALS, JANUARY 2021−SEPTEMBER 2024 193
TABLE 130 ARTHREX: COMPANY OVERVIEW 194
TABLE 131 ARTHREX: PRODUCTS OFFERED 194
TABLE 132 ENOVIS: COMPANY OVERVIEW 200
TABLE 133 ENOVIS: PRODUCTS OFFERED 201
TABLE 134 ENOVIS: PRODUCT LAUNCHES, JANUARY 2021−SEPTEMBER 2024 203
TABLE 135 ENOVIS: DEALS, JANUARY 2021−SEPTEMBER 2024 203
TABLE 136 ENOVIS: EXPANSIONS, JANUARY 2021− AUGUST 2024 204
TABLE 137 ACUMED: COMPANY OVERVIEW 205
TABLE 138 ACUMED: PRODUCTS OFFERED 205
TABLE 139 ACUMED: PRODUCT LAUNCHES, JANUARY 2021−SEPTEMBER 2024 207
TABLE 140 ACUMED: DEALS, JANUARY 2021−SEPTEMBER 2024 208
TABLE 141 ACUMED: EXPANSIONS, JANUARY 2021− AUGUST 2024 208
TABLE 142 ORTHOFIX MEDICAL: COMPANY OVERVIEW 209
TABLE 143 ORTHOFIX MEDICAL: PRODUCTS OFFERED 210
TABLE 144 ORTHOFIX MEDICAL: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2021−SEPTEMBER 2024 212
TABLE 145 ORTHOFIX MEDICAL: DEALS, JANUARY 2021−SEPTEMBER 2024 212
TABLE 146 MICROPORT SCIENTIFIC CORPORATION: COMPANY OVERVIEW 213
TABLE 147 MICROPORT SCIENTIFIC CORPORATION: PRODUCTS OFFERED 214
TABLE 148 MICROPORT SCIENTIFIC CORPORATION: PRODUCT LAUNCHES,
JANUARY 2021−SEPTEMBER 2024 215
TABLE 149 MICROPORT SCIENTIFIC CORPORATION: DEALS, JANUARY 2021−
SEPTEMBER 2024 216
TABLE 150 CONMED CORPORATION: COMPANY OVERVIEW 217
TABLE 151 CONMED CORPORATION: PRODUCTS OFFERED 218
TABLE 152 CONMED CORPORATION: DEALS, JANUARY 2021−SEPTEMBER 2024 219
TABLE 153 MEDACTA INTERNATIONAL: COMPANY OVERVIEW 220
TABLE 154 MEDACTA INTERNATIONAL: PRODUCTS OFFERED 221
TABLE 155 MEDACTA INTERNATIONAL: PRODUCT APPROVALS, JANUARY 2021−
SEPTEMBER 2024 222
TABLE 156 MEDACTA INTERNATIONAL: DEALS, JANUARY 2021−SEPTEMBER 2024 222
TABLE 157 MEDACTA INTERNATIONAL: EXPANSIONS, JANUARY 2021−SEPTEMBER 2024 223
TABLE 158 PARAGON 28: COMPANY OVERVIEW 224
TABLE 159 PARAGON 28: PRODUCTS OFFERED 225
TABLE 160 PARAGON 28: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021−
SEPTEMBER 2024 227
TABLE 161 PARAGON 28: DEALS, JANUARY 2021−SEPTEMBER 2024 228
TABLE 162 MERIL LIFE SCIENCES: COMPANY OVERVIEW 229
TABLE 163 MERIL LIFE SCIENCES: PRODUCTS OFFERED 229
TABLE 164 MERIL LIFE SCIENCES: EXPANSIONS, JANUARY 2021−SEPTEMBER 2024 231
LIST OF FIGURES
FIGURE 1 ORTHOPEDIC IMPLANTS MARKET SEGMENTATION 23
FIGURE 2 ORTHOPEDIC IMPLANTS MARKET: RESEARCH DESIGN 25
FIGURE 3 ORTHOPEDIC IMPLANTS MARKET: KEY PRIMARY SOURCES (DEMAND- AND SUPPLY-SIDE PARTICIPANTS) 27
FIGURE 4 ORTHOPEDIC IMPLANTS: KEY INSIGHTS FROM PRIMARY INTERVIEWS 28
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY- AND
DEMAND-SIDE PARTICIPANTS 28
FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE,
DESIGNATION, AND REGION 29
FIGURE 7 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 30
FIGURE 8 ORTHOPEDIC IMPLANTS MARKET SIZE ESTIMATION:
COMPANY REVENUE ESTIMATION 31
FIGURE 9 ORTHOPEDIC IMPLANTS MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH 32
FIGURE 10 CAGR PROJECTION: SUPPLY-SIDE ANALYSIS 33
FIGURE 11 DATA TRIANGULATION METHODOLOGY 34
FIGURE 12 ORTHOPEDIC IMPLANTS MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION) 37
FIGURE 13 ORTHOPEDIC IMPLANTS MARKET, BY MATERIAL, 2024 VS. 2029 (USD MILLION) 38
FIGURE 14 ORTHOPEDIC IMPLANTS MARKET, BY END USER, 2024 VS. 2029 (USD MILLION) 38
FIGURE 15 GEOGRAPHIC SNAPSHOT OF ORTHOPEDIC IMPLANTS MARKET 39
FIGURE 16 RISING PREVALENCE OF ORTHOPEDIC DISEASES AND DISORDERS TO
DRIVE MARKET GROWTH 40
FIGURE 17 HIP IMPLANTS SEGMENT TO REGISTER SIGNIFICANT GROWTH IN
NORTH AMERICAN MARKET 41
FIGURE 18 HYBRID IMPLANTS TO HOLD LARGEST SHARE IN EUROPE 41
FIGURE 19 HOSPITALS & SURGICAL CENTERS SEGMENT TO REGISTER SIGNIFICANT GROWTH IN APAC END-USER MARKET 42
FIGURE 20 CHINA TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD 43
FIGURE 21 ORTHOPEDIC IMPLANTS MARKET: DRIVERS, RESTRAINTS,
OPPORTUNITIES, AND CHALLENGES 44
FIGURE 22 ORTHOPEDIC IMPLANTS MARKET: VALUE CHAIN ANALYSIS 50
FIGURE 23 ORTHOPEDIC IMPLANTS MARKET: SUPPLY CHAIN ANALYSIS 52
FIGURE 24 ORTHOPEDIC IMPLANTS MARKET: ECOSYSTEM ANALYSIS 53
FIGURE 25 PREMARKET NOTIFICATION: 510(K) APPROVALS FOR MEDICAL DEVICES 58
FIGURE 26 CANADA: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES 60
FIGURE 27 EUROPE: CE APPROVAL PROCESS FOR MEDICAL DEVICES 62
FIGURE 28 INVESTMENT AND FUNDING SCENARIO IN ORTHOPEDIC IMPLANTS MARKET, 2019−2023 (USD MILLION) 68
FIGURE 29 NUMBER OF INVESTOR DEALS IN ORTHOPEDIC IMPLANTS MARKET,
BY KEY PLAYER, 2019−2023 (UNIT) 69
FIGURE 30 VALUE OF INVESTOR DEALS IN ORTHOPEDIC IMPLANTS MARKET, BY KEY PLAYER, 2018–2022 (USD MILLION) 69
FIGURE 31 AVERAGE SELLING PRICE OF ORTHOPEDIC IMPLANTS, BY PRODUCT, 2023 (USD) 70
FIGURE 32 AVERAGE SELLING PRICE OF ORTHOPEDIC IMPLANTS, BY REGION, 2023 (USD) 71
FIGURE 33 ORTHOPEDIC IMPLANTS MARKET: PATENT ANALYSIS, 2013–2023 74
FIGURE 34 ORTHOPEDIC IMPLANTS MARKET: PORTER’S FIVE FORCES ANALYSIS 76
FIGURE 35 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF ORTHOPEDIC IMPLANTS 78
FIGURE 36 KEY BUYING CRITERIA, BY END USER 79
FIGURE 37 NEW REVENUE POCKETS FOR PLAYERS IN ORTHOPEDIC IMPLANTS MARKET 84
FIGURE 38 MARKET POTENTIAL OF AI/GENERATIVE AI IN ORTHOPEDIC IMPLANTS MARKET 86
FIGURE 39 NORTH AMERICA: ORTHOPEDIC IMPLANTS MARKET SNAPSHOT 109
FIGURE 40 ASIA PACIFIC: ORTHOPEDIC IMPLANTS MARKET SNAPSHOT 125
FIGURE 41 REVENUE SHARE ANALYSIS OF KEY PLAYERS IN ORTHOPEDIC
IMPLANTS MARKET (2019−2023) 147
FIGURE 42 MARKET SHARE ANALYSIS OF KEY PLAYERS (2023) 148
FIGURE 43 ORTHOPEDIC IMPLANTS MARKET: COMPANY EVALUATION
MATRIX (KEY PLAYERS), 2023 150
FIGURE 44 ORTHOPEDIC IMPLANTS MARKET: COMPANY FOOTPRINT 151
FIGURE 45 ORTHOPEDIC IMPLANTS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023 156
FIGURE 46 EV/EBITDA OF KEY VENDORS 159
FIGURE 47 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK
BETA OF KEY VENDORS 160
FIGURE 48 ORTHOPEDIC IMPLANTS MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS 161
FIGURE 49 ZIMMER BIOMET HOLDINGS: COMPANY SNAPSHOT (2023) 164
FIGURE 50 STRYKER CORPORATION: COMPANY SNAPSHOT (2023) 170
FIGURE 51 JOHNSON & JOHNSON MEDTECH: COMPANY SNAPSHOT (2023) 177
FIGURE 52 SMITH+NEPHEW: COMPANY SNAPSHOT (2023) 182
FIGURE 53 B. BRAUN: COMPANY SNAPSHOT (2023) 187
FIGURE 54 GLOBUS MEDICAL: COMPANY SNAPSHOT (2023) 191
FIGURE 55 ENOVIS: COMPANY SNAPSHOT (2023) 201
FIGURE 56 ORTHOFIX MEDICAL: COMPANY SNAPSHOT (2023) 210
FIGURE 57 MICROPORT SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2023) 214
FIGURE 58 CONMED CORPORATION: COMPANY SNAPSHOT (2023) 218
FIGURE 59 MEDACTA INTERNATIONAL: COMPANY SNAPSHOT (2023) 221
FIGURE 60 PARAGON 28: COMPANY SNAPSHOT (2023) 225
MarketsandMarkets（マーケッツアンドマーケッツ）は世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。広範な市場を対象にした市場調査レポートを出版しています。
※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。
ライセンス別価格表
調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。
ライセンスタイプ1
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD4,950 | USD6,650 | USD8,150 | USD10,000 |
ライセンスタイプ2
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD7,150 | USD8,500 | USD9,650 | USD11,000 |
ライセンスタイプ3
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD8,150 | お問合せください | お問合せください | お問合せください |
ライセンスタイプ4
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD9,000 | USD10,500 | USD12,000 | USD13,500 |
ミニレポート ※定性調査にフォーカスした調査レポートです。詳細はお問合せください。
| シングルユーザ | コーポレート |
| USD 2,650 | USD 4,250 |
ご購入に関するご案内
価格・納期について
- 価格
- ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
- ライセンス
- シングルユーザライセンス
- 1名のみレポートファイルのご利用が可能です。
- マルチユーザライセンス
- 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
- コーポレートライセンス
- 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
- エンタープライズサイトライセンス
- 特別ライセンスです。適用範囲についてはお問合せください。
- シングルユーザライセンス
- 納品形態
- Eメール
- 納期
- 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）
ご注文方法
- レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。
その他
- 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。
株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。
最新調査レポート
- 自動車用アラミド繊維市場規模、シェア、動向、2030年までの世界予測 2025-12-15
- ポリヒドロキシアルカノエート (PHA) 市場規模、シェア、動向、2030年までの世界予測 2025-12-15
- 複合輸送市場規模、シェア、動向、2032年までの世界予測 2025-12-12
- 有機酸市場規模、シェア、動向、2030年までの世界予測 2025-12-11
- ハイブリッドボンディング市場規模、シェア、動向、2032年までの世界予測 2025-12-11